CardioSource WorldNews October 2015 | Page 25

that middle-aged adults should receive a flu vaccine. However, the authors note that the interpretation of vaccine effectiveness is complex and the vaccination may not be equally protective against AMI the entire year. Four of the six studies they examined on vaccinations were performed during the flu season. Additionally, the effectiveness of the annual flu vaccine varies depending on the circulating strain. The timing of the vaccine is also important. The vaccine must be administered prior to the AMI event for it to be a valid predictor of AMI risk. The authors stress that physicians should be aware of the need to offer flu vaccinations to patients with cardiovascular disease, and that McNamara and colleagues add that their methodology reflects accepted standards for publicly reported outcome measures. cardiologists should consider offering vaccination following an AMI, prior to hospital discharge or during cardiac rehabilitation or follow-up. Additionally, cost-effectiveness studies are needed to compare the flu vaccine and primary and secondary prevention for AMI in order to further inform preventative policy. Barnes M, Heywood AE, Mahimbo A, et al. Heart. 2015;0:1-10. ACC.org/CSWN Researchers Develop First Outcome Measures for EHRs A study recently published in Medical Care maps out the first outcome measure to use with electronic health records (EHRs), measuring 30-day mortality after acute myocardial infarction (AMI). Currently, the Centers for Medicare and Medicaid Services (CMS) publicly reported hospital outcome measures use claims data for risk adjustment, which many clinicians have expressed concerns with. With the support of CMS, Robert L. McNamara MD, MHS, and colleagues developed an eMeasure of hospital 30-day all-cause risk-standardized mortality for patients with AMI. Their goal was to create an outcome measure that would be suitable for national public reporting by using data elements that are routinely collected in current practice, captured in standards formats and feasibly retrieved from current EHR systems. The developed eMeasure was recently endorsed by the National Quality Forum (NQF). Researchers used data from the ACC/American Heart Association Action Registry Get With the Guidelines, which captures information about AMI patients at 450 hospitals nationwide. They matched admissions for AMI in the registry that were discharged between Jan. 1 and Dec. 31, 2009, with admissions for AMI from CMS Medicare Part A discharged during the same time period. The researchers also derived a cohort for the validation in a similar fashion based on the claims between Jan. 1 and Dec. 31, 2010. They then calculated the hospital-specific risk-standardization mortality rate at the ratio of predicted number of death to expected number of deaths, multiplied by the nation adjusted mortality rate. Then,